Biogen, Medicines Co. deal

BGEN licensed all intellectual and manufacturing rights to Hirulog (bivalirudin) direct thrombin inhibitor

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE